Journals / Türk Onkoloji Dergisi / 2016 / Cilt: 31 - Sayı: 3

Leptomeningeal Carcinomatosis in a Krukenberg Tumor Associated with Signet Ring Cell Gastric Cancer

Pages
109–112
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinical improvement can be achieved with current treatment modalities, including radiotherapy, chemotherapy, or targeted molecules.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Leptomeningeal carcinomatosis (LCM) is a rare complication of gastric cancer.
📊
Key Findings & Data:A 28-year-old woman with signet ring cell gastric cancer associated with Krukenberg tumor was admitted with persistent headache, nausea, vomiting, vertigo, and diplopia.
💡
Conclusion & Impact:Clinical improvement can be achieved with current treatment modalities, including radiotherapy, chemotherapy, or targeted molecules.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Leptomeningeal carcinomatosis (LCM) is a rare complication of gastric cancer. It usually occurs late in advanced stage of disease and is sometimes misdiagnosed as toxicity of chemotherapeutic agents. Here we report a rare case of gastric cancer that developed LCM in follow-up. A 28-year-old woman with signet ring cell gastric cancer associated with Krukenberg tumor was admitted with persistent headache, nausea, vomiting, vertigo, and diplopia. Linear appearance of contrast enhancement in cerebellar fissures and around cranial nerves was seen in magnetic resonance imaging and cerebrospinal fluid was hypercellular with numerous carcinoma cells. LMC was confirmed and treated with intrathecal methotrexate and additional whole-brain irradiation. LCM is a rare complication, but occurs more often than expected and is often misdiagnosed. If patient who is being treated for gastric cancer presents with neurological symptoms, LCM should be kept in mind. Clinical improvement can be achieved with current treatment modalities, including radiotherapy, chemotherapy, or targeted molecules.

🔖

Cite This Article

SAĞLAM, K., BAŞGÖZ, B. B., ARPACI, F., ERDEM, G., ASLAN, H., YILDIZ, B., AYDIN, A. (2022). Leptomeningeal Carcinomatosis in a Krukenberg Tumor Associated with Signet Ring Cell Gastric Cancer. Türk Onkoloji Dergisi, Cilt: 31 - Sayı: 3, 109–112. https://ajindex.com/articles/639308

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Braeuninger S, Mawrin C, Malfertheiner P, Schildhaus HU, Seiler C, Dietzmann K, et al. Gastric adenocarcinoma with leptomeningeal carcinomatosis as the presenting manifestation: an autopsy case report. Eur J Gastroenterol Hepatol 2005;17(5):577-9
  2. Posner JB. Leptomeningeal metastases. In: Posner JB, editor. Neurologic complications of cancer. Philadelphia, PA: F. A. Davis Company; 1995. p. 143-71
  3. DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998;38(2- 3):245-52
  4. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25(2):103-19
  5. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49(4):759-72
  6. Lee JL, Kang YK, Kim TW, Chang HM, Lee GW, Ryu MH, et al. Leptomeningeal carcinomatosis in gastric cancer. J Neurooncol 2004;66:167-74
  7. Raj KP, Sanati H, Mehta RS, Zell JA. Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer. Anticancer Drugs 2009;20(4):301- 4
  8. Emoto S, Ishigami H, Yamaguchi H, Yamashita H, Kaisaki S, Kitayama J. Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancer. Gastric Cancer 2011;14(4):390-5
  9. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology 2010;74(18):1449-54. 10.Groves MD. New strategies in the management of leptomeningeal metastases. Arch Neurol 2010;67(3):305- 12. 11.Lisenko Y, Kumar AJ, Yao J, Ajani J, Ho L. Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature. Am J Clin Oncol 2003;26(2):165-70. 12.Fisher MA, Weiss RB. Carcinomatous meningitis in gastrointestinal malignancies. South Med J 1979;72(8):930-2. 13.Kim DY, Lee KW, Yun T, Park SR, Jung JY, Kim DW, et al. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 2003;33(12):608-12. 14.Siegal T, Lossos A, Pfeffer MR. Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 1994;44(8):1463-9. 15.Dhruva N, Socinski MA. Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib. J Clin Oncol 2009;27(22):e31-2. 16.Gadgeel SM, Gandhi